Inflammatory Bowel Disease Patients Are Frequently Nonadherent to Scheduled Induction and Maintenance Infliximab Therapy: A Canadian Cohort Study

BACKGROUND: Adherence to maintenance medication regimens in inflammatory bowel disease patients has traditionally been poor. Although infliximab has demonstrated efficacy in inducing and maintaining disease remission, adherence to regularly scheduled infliximab infusions is required to maintain ther...

Full description

Saved in:
Bibliographic Details
Main Authors: Christopher Ma, Chad J Evaschesen, Grenvil Gracias, Vivian W Huang, Darryl K Fedorak, Karen I Kroeker, Levinus A Dieleman, Brendan P Halloran, Richard N Fedorak
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2015/378628
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832556520250802176
author Christopher Ma
Chad J Evaschesen
Grenvil Gracias
Vivian W Huang
Darryl K Fedorak
Karen I Kroeker
Levinus A Dieleman
Brendan P Halloran
Richard N Fedorak
author_facet Christopher Ma
Chad J Evaschesen
Grenvil Gracias
Vivian W Huang
Darryl K Fedorak
Karen I Kroeker
Levinus A Dieleman
Brendan P Halloran
Richard N Fedorak
author_sort Christopher Ma
collection DOAJ
description BACKGROUND: Adherence to maintenance medication regimens in inflammatory bowel disease patients has traditionally been poor. Although infliximab has demonstrated efficacy in inducing and maintaining disease remission, adherence to regularly scheduled infliximab infusions is required to maintain therapeutic trough drug levels and prevent the development of anti-infliximab antibodies.
format Article
id doaj-art-8dfd2d200003405ead0b6d20c4c75971
institution Kabale University
issn 2291-2789
2291-2797
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-8dfd2d200003405ead0b6d20c4c759712025-02-03T05:45:12ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972015-01-0129630931410.1155/2015/378628Inflammatory Bowel Disease Patients Are Frequently Nonadherent to Scheduled Induction and Maintenance Infliximab Therapy: A Canadian Cohort StudyChristopher Ma0Chad J Evaschesen1Grenvil Gracias2Vivian W Huang3Darryl K Fedorak4Karen I Kroeker5Levinus A Dieleman6Brendan P Halloran7Richard N Fedorak8Division of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaDivision of Gastroenterology, University of Alberta, Edmonton, Alberta, CanadaBACKGROUND: Adherence to maintenance medication regimens in inflammatory bowel disease patients has traditionally been poor. Although infliximab has demonstrated efficacy in inducing and maintaining disease remission, adherence to regularly scheduled infliximab infusions is required to maintain therapeutic trough drug levels and prevent the development of anti-infliximab antibodies.http://dx.doi.org/10.1155/2015/378628
spellingShingle Christopher Ma
Chad J Evaschesen
Grenvil Gracias
Vivian W Huang
Darryl K Fedorak
Karen I Kroeker
Levinus A Dieleman
Brendan P Halloran
Richard N Fedorak
Inflammatory Bowel Disease Patients Are Frequently Nonadherent to Scheduled Induction and Maintenance Infliximab Therapy: A Canadian Cohort Study
Canadian Journal of Gastroenterology and Hepatology
title Inflammatory Bowel Disease Patients Are Frequently Nonadherent to Scheduled Induction and Maintenance Infliximab Therapy: A Canadian Cohort Study
title_full Inflammatory Bowel Disease Patients Are Frequently Nonadherent to Scheduled Induction and Maintenance Infliximab Therapy: A Canadian Cohort Study
title_fullStr Inflammatory Bowel Disease Patients Are Frequently Nonadherent to Scheduled Induction and Maintenance Infliximab Therapy: A Canadian Cohort Study
title_full_unstemmed Inflammatory Bowel Disease Patients Are Frequently Nonadherent to Scheduled Induction and Maintenance Infliximab Therapy: A Canadian Cohort Study
title_short Inflammatory Bowel Disease Patients Are Frequently Nonadherent to Scheduled Induction and Maintenance Infliximab Therapy: A Canadian Cohort Study
title_sort inflammatory bowel disease patients are frequently nonadherent to scheduled induction and maintenance infliximab therapy a canadian cohort study
url http://dx.doi.org/10.1155/2015/378628
work_keys_str_mv AT christopherma inflammatoryboweldiseasepatientsarefrequentlynonadherenttoscheduledinductionandmaintenanceinfliximabtherapyacanadiancohortstudy
AT chadjevaschesen inflammatoryboweldiseasepatientsarefrequentlynonadherenttoscheduledinductionandmaintenanceinfliximabtherapyacanadiancohortstudy
AT grenvilgracias inflammatoryboweldiseasepatientsarefrequentlynonadherenttoscheduledinductionandmaintenanceinfliximabtherapyacanadiancohortstudy
AT vivianwhuang inflammatoryboweldiseasepatientsarefrequentlynonadherenttoscheduledinductionandmaintenanceinfliximabtherapyacanadiancohortstudy
AT darrylkfedorak inflammatoryboweldiseasepatientsarefrequentlynonadherenttoscheduledinductionandmaintenanceinfliximabtherapyacanadiancohortstudy
AT karenikroeker inflammatoryboweldiseasepatientsarefrequentlynonadherenttoscheduledinductionandmaintenanceinfliximabtherapyacanadiancohortstudy
AT levinusadieleman inflammatoryboweldiseasepatientsarefrequentlynonadherenttoscheduledinductionandmaintenanceinfliximabtherapyacanadiancohortstudy
AT brendanphalloran inflammatoryboweldiseasepatientsarefrequentlynonadherenttoscheduledinductionandmaintenanceinfliximabtherapyacanadiancohortstudy
AT richardnfedorak inflammatoryboweldiseasepatientsarefrequentlynonadherenttoscheduledinductionandmaintenanceinfliximabtherapyacanadiancohortstudy